[1] BALDESSARINI R J. Drugs for the treatment of psychiatric disorders. In：Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. Eds.：HARDMAN J G，LIMBIRD L E，GOODMAN-GILMAN A. New York：McGraw Hill，2001：447-483.

[2] BENDTSEN L，JENSEN R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology，2004，62（10）：1706-1711.

[3] CARDENAS D D，WARMS C A，TURNER J A，et al. Efficacy of amitriptyline for relief of pain in spinal cord injury：results of a randomized controlled trial. Pain，2002，96：365-373.

[4] Cook，R J & D L Sackett：The number needed to treat：a clinical useful measure of treatment effect. Brit Med J，1995，310：452-454.

[5] DHARMSHAKTU P，TAYAL V，KALRA B S. Efficacy of antidepressants as analgesics：a review. J Clin Pharmacol，2012，52（1）：6-17.

[6] EISENACH J C，GEBHART G F. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology，1995，83：1046-1054.

[7] GERNER P，MUJTABA M，SINNOTT C J，et al. Amitriptyline versus bupivacaine in rat sciatic nerve blockade. Anesthesiology，2001，94：661-667.

[8] GILRON I. Antidepressant drugs for postsurgical pain：current status and future directions. Drugs，2016，76（2）：159-167.

[9] LEIJON G，BOIVIE J. Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain，1989，36：27-36.

[10] MICÓ J A，ARDID D，BERROCOSO E，et al. Antidepressants and pain. Trends in Pharmacological Sciences，2006，27：348-354.

[11] KIEBURTZ K，SIMPSON D，YIANNOUTSOS C，et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology，1998，51（6）：1682-1688.

[12] LYNCH M E，CLARK A J，SAWYNOK J，et al. Topical amitriptyline and ketamine in neuropathic pain syndromes：an open-label study. J Pain，2005，6（10）：644-649.

[13] MJELLEM N，LUND A，HOLE K. Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice. Neuropharmacology，1993，32：591-595.

[14] FINNERUP N B，OTTO M，MCQUAY H J，et al. Algorithm for neuropathic pain treatment：an evidence based proposal. Pain，2005，118：289-305.

[15] TAUBEN D. Nonopioid medications for pain. Phys Med Rehabil Clin N Am，2015，26（2）：219-248.

[16] RASMUSSEN B B，BRØSEN K. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? Therap Drug Monit，2001，22：143-154.

[17] REISBY N，GRAM L F，BECH P，et al. Christensen：Imipramine：Clinical effects and pharmacokineticvariability. Psychopharmacology，1977，54：263-272.

[18] ROWBOTHAM M C，GOLI V，KUNZ N R，et al. Venlafaxine extended release in the treatment of painful diabetic polyneuropathy：a double-blind，placebo-controlled study. Pain，2004，110：697-706.

[19] SAMBORSKI W，LEZANSKA-SZPERA M，RYBAKOWSKI J K. Open trial of mirtazapine in patientswith fibromyalgia. Pharmacopsychiatry，2004，37（4）：168-170.

[20] SCHREIBER S，BLEICH A，PICK C G. Venlafaxine and mirtazapine：different mechanisms of antidepressant action，common opioid-mediated antinociceptive effects - a possible opioid involvement in severe depression? J Mol Neurosci，2002，18：143-149.

[21] SEMENCHUCK M R，SHERMAN S，DAVIS B. Double-blind，randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology，2001，57：1583-1588.

[22] SINDRUP S H，OTTO M，FINNERUP N B. Antidepressants in the treatment of neuropathic pain. Basic &Clinical Pharmacology & Toxicology，2005，96：399-409.

[23]史妙，王锦琰，罗非．疼痛和抑郁．中国药物与临床，2009，9（9）：789-792.

[24] SIMPSON D A. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromusc Dis，2001；3（2）：53-62.

[25] SINDRUP S H，GRAM L F，BRØSEN K，et al. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain，1990，42：135-144.

[26] SINDRUP S H，GRAM L F，SKJOLD T，et al. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Brit J Clin Pharmacol，1990，30：683-691.

[27] SINDRUP S H. Antidepressants and chronic pain. In：Clinical pain management. Chronic pain. Eds：JENSEN T S，WILSON P，RICE A S. UK：London，2003：239-249.

[28] SUDOH Y，CAHOON E E，GERNER P，et al. Tricyclic antidepressants as long-acting local anesthetics.Pain，2003，103（1-2）：49-55.

[29] YOKAGAW F，KIUCHI Y，ISHIKAWA Y，et al. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg，2002，95：163-168.